Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001227198 | SCV001399544 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2024-12-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe144Tyrfs*5) in the SCN1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN1A are known to be pathogenic (PMID: 17347258, 18930999). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Dravet syndrome (PMID: 23195492). In at least one individual the variant was observed to be de novo. This variant is also known as V144fsX148. ClinVar contains an entry for this variant (Variation ID: 929413). For these reasons, this variant has been classified as Pathogenic. |
Laboratory of Medical Genetics, |
RCV001194607 | SCV001364260 | pathogenic | Severe myoclonic epilepsy in infancy | 2020-02-19 | no assertion criteria provided | clinical testing |